Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2026-03-01 @ 4:46 PM
Study NCT ID:
NCT01467505
Status:
TERMINATED
Last Update Posted:
2015-06-18
First Post:
2011-11-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hepatitis C | View |
Keywords: